Mab_3168c, a putative acetyltransferase, enhances adherence, intracellular survival and antimicrobial resistance of Mycobacterium abscessus

PLoS One. 2013 Jun 28;8(6):e67563. doi: 10.1371/journal.pone.0067563. Print 2013.

Abstract

Mycobacterium abscessus is a non-tuberculous mycobacterium. It can cause diseases in both immunosuppressed and immunocompetent patients and is highly resistant to multiple antimicrobial agents. M. abscessus displays two different colony morphology types: smooth and rough morphotypes. Cells with a rough morphotype are more virulent. The purpose of this study was to identify genes responsible for M. abscessus morphotype switching. With transposon mutagenesis, a mutant with a Tn5 inserted into the promoter region of the mab_3168c gene was found to switch its colonies from a rough to a smooth morphotype. This mutant had a higher sliding motility but a lower ability to form biofilms, aggregate in culture, and survive inside macrophages. Results of bioinformatic analyses suggest that the putative Mab_3168c protein is a member of the GCN5-related N-acetyltransferase superfamily. This prediction was supported by the demonstration that the mab_3168c gene conferred M. abscessus and M. smegmatis cells resistance to amikacin. The multiple roles of mab_3168c suggest that it could be a potential target for development of therapeutic regimens to treat diseases caused by M. abscessus.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acetyltransferases / genetics*
  • Acetyltransferases / metabolism*
  • Amikacin / pharmacology
  • Anti-Infective Agents / pharmacology
  • Biofilms / growth & development
  • Computational Biology / methods
  • Drug Resistance, Microbial / genetics*
  • Hydrophobic and Hydrophilic Interactions / drug effects
  • Macrophages / metabolism
  • Muramidase / drug effects
  • Muramidase / genetics
  • Muramidase / metabolism
  • Mutation / genetics
  • Mycobacterium / drug effects
  • Mycobacterium / enzymology*
  • Mycobacterium / genetics
  • Mycobacterium / metabolism
  • Mycobacterium Infections, Nontuberculous / drug therapy
  • Mycobacterium Infections, Nontuberculous / enzymology*
  • Mycobacterium Infections, Nontuberculous / genetics
  • Mycobacterium Infections, Nontuberculous / metabolism
  • Nontuberculous Mycobacteria / drug effects
  • Nontuberculous Mycobacteria / enzymology*
  • Nontuberculous Mycobacteria / genetics
  • Nontuberculous Mycobacteria / metabolism
  • Promoter Regions, Genetic / genetics

Substances

  • Anti-Infective Agents
  • Amikacin
  • Acetyltransferases
  • Muramidase

Grants and funding

This work was supported by grant NSC 99-2320-B-006-MY3 from the National Science Council, Taiwan, ROC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.